Earnings Feed
Start Free
BELITE BIO, INC·4

Apr 23, 4:23 PM ET

Lin Yu-Hsin 4

Research Summary

AI-generated summary

Updated

Belite Bio CEO Lin Yu-Hsin Receives 10,000-Share RSU Award

What Happened
Lin Yu-Hsin, CEO of Belite Bio, had 10,000 restricted stock units (RSUs) vest on April 21, 2026. The Form 4 reports an "other acquisition" of 10,000 ordinary shares at a reported price of $0.00 (i.e., shares issued on vesting), with a total reported cash value of $0.

Key Details

  • Transaction date: 2026-04-21; reported on Form 4 filed 2026-04-23 (timely filing).
  • Transaction type/code: Other acquisition (code J) — RSU vesting resulting in issuance of 10,000 shares.
  • Price: $0.00 per share (shares issued upon vesting, not purchased).
  • Shares owned after transaction: Not disclosed in the filing.
  • Footnote: RSUs were granted on 09/15/2025 and vested when performance criteria were met on 04/21/2026, causing issuance of 10,000 ordinary shares.
  • No sale, tax-withholding sale, or 10b5-1 plan is indicated in the filing.

Context
This was a compensation/award-related issuance (performance-based RSU vesting), not an open-market purchase or sale. Such vesting events are routine corporate compensation and do not by themselves indicate insider buying or selling intentions.